InDex Pharmaceuticals has entered into a conditional agreement regarding a reverse merger with Flerie
20 May 2024 – InDex Pharmaceuticals Holding AB (publ) ("InDex Pharmaceuticals" or the "Company") has today entered into a conditional agreement to acquire all shares in Flerie Invest AB. The acquisition is made through an issue in kind of 6,073,952,948 new shares in the Company, following which Flerie Invest AB's shareholders will initially hold approximately 91.9 per cent of the shares and InDex Pharmaceuticals' existing shareholders will initially hold approximately 8.1 per cent of the shares in the Company.The transaction in brief · InDex Pharmaceuticals has entered into an
